Related Experiment Video
Updated: Aug 6, 2025

Orthotopic Ovarian Transplantation Procedures to Investigate the Life- and Health-span Influence of Ovarian Senescence in Female Mice
Published on: February 12, 2018
Male Reproduction and Aging.
Maria Gabriela Figueiredo1, Thiago Gagliano-Jucá2, Shehzad Basaria3
1Division of Endocrinology and Metabolism, Brigham and Women's Hospital, Harvard Medical School, 221 Longwood Avenue, BLI 541, Boston, MA 02115, USA; Department of Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.
Late-onset hypogonadism is uncommon. Testosterone therapy offers modest benefits for some older men, but risks for prostate cancer and cardiovascular events require further study.
Area of Science:
- Endocrinology
- Men's Health
- Geriatrics
Background:
- Recent studies indicate a low prevalence of symptomatic late-onset hypogonadism (age-related low testosterone).
- Testosterone therapy in middle-aged and older men shows modest efficacy for specific symptoms like sexual dysfunction, mood, bone density, and anemia.
Purpose of the Study:
- To evaluate the benefits and risks of testosterone therapy in older men with age-related testosterone decline.
- To clarify the impact of testosterone therapy on prostate cancer risk and major adverse cardiovascular events.
Main Methods:
- Review of recent population studies and clinical trials on testosterone therapy.
- Analysis of efficacy in improving sexual function, mood, bone density, and anemia.
- Assessment of uncertainties regarding prostate cancer and cardiovascular risks.
Main Results:
- Syndromic prevalence of age-related low testosterone is low.
- Testosterone therapy provides modest improvements in sexual function, mood, bone density, and anemia in select older men.
- The effects on prostate cancer risk and major adverse cardiovascular events are not yet clear.
Conclusions:
- Testosterone therapy may benefit select older men with age-related testosterone decline.
- Further research, including the ongoing TRAVERSE trial, is needed to determine the risks associated with testosterone therapy, particularly concerning prostate cancer and cardiovascular events.
More Related Videos
Related Concept Videos
Menopause
Bone Disorders
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Oogenesis
The Effect of Aging on Tissues
Testosterone: Functions and Regulation
Aging
Cellular Clock Theory
The cellular clock theory posits that the human lifespan is closely tied to the finite capacity of cells to divide, a phenomenon governed by telomeres, which are protective caps at the ends of...

